It is a pharma private limited company based in Kolkata, West Bengal, India, established in 2019.
2019 | Kolkata, West Bengal, India | ActiveXenex Pharmaceuticals Private Limited, a active private limited company, was established on 20 February 2019 in Kolkata, West Bengal, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U24290WB2019PTC230567. Registered under ROC Roc Kolkata. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.
It upholds a compliant status. Its leadership includes Vatsal Arya (Director), Pravisha Arya (Director), Alok Arya (Director). Past directors included Vatsal Arya, Pravisha Arya, Ashok Arya. It holds ₹9.90 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 43, Kailash Bose Street, Kolkata, West Bengal, 700006.
U24290WB2019PTC230567
230567
20 February 2019
₹1.00 M
₹1.00 M
Roc Kolkata
Unlisted
Active
Explore comprehensive insights into Xenex Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vatsal Arya | Director | 10 Jul 2021 | Current |
| Pravisha Arya | Director | 06 May 2024 | Current |
| Alok Arya | Director | 05 Dec 2019 | Current |
| Amit Arya | Director | 20 Feb 2019 | Current |
| Ashok Arya | Director | 10 Jul 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Nov 2021 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2024 | Past |
| Pramod Abcsdd | Additional Director | 30 Nov 2021 | Past |
| Pramod Abcsdd | Director | 09 Dec 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Xenex Pharmaceuticals Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 9.46% increase. The company also saw a substantial fall in profitability, with a 20.48% decrease in profit. The company's net worth moved up by a moderate rise of 3.19%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Xenex Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹9,900,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Aug 2025 | Hdfc Bank Limited | ₹9.90 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Xenex Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Xenex Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Xenex Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge with Hdfc Bank Limited amounted to Rs. 9.90 M with Charge ID 101142833 was registered on 21 Aug 2025. was completed.
Xenex Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity Pravisha Arya was appointed as a Director was appointed as a Director on 06 May 2024 & has been associated with this company since 1 year 6 months . was completed.
Xenex Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kolkata. was recorded as a recent event.
The activity Vatsal Arya was appointed as a Director was appointed as a Director on 10 Jul 2021 & has been associated with this company since 4 years 4 months . was completed.
Ashok Arya was appointed as a Director was appointed as a Director on 10 Jul 2021 & has been associated with this company since 4 years 4 months . was recorded as a recent event.
The CIN of Xenex Pharmaceuticals Private Limited is U24290WB2019PTC230567.
Xenex Pharmaceuticals Private Limited is headquartered at 43, Kailash Bose Street, Kolkata, West Bengal, 700006.
Xenex Pharmaceuticals Private Limited was incorporated on 20 February 2019.
The current directors of Xenex Pharmaceuticals Private Limited are
The primary industry of Xenex Pharmaceuticals Private Limited is Pharma.
Xenex Pharmaceuticals Private Limited is unlisted.
The authorized capital of Xenex Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.
The compliance status of Xenex Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX